Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1237599 | 0.87 | HTT (0.45) | HTTLMNATSHRPOLBCYP3A4 | |
| SCHEMBL1238230 | 0.85 | HTT (0.47) | HTTLMNATSHRPOLBCYP3A4 | |
| SCHEMBL1237573 | 0.85 | HTT (0.51) | HTTLMNATSHRPOLBCYP3A4 | |
| SCHEMBL11795248 | 0.83 | HTT (0.54) | HTTLMNATSHRPOLBCYP3A4 | |
| SCHEMBL706323 | 0.83 | HTT (0.54) | HTTLMNATSHRPOLBCYP3A4 | |
| SCHEMBL1238035 | 0.83 | HTT (0.54) | HTTLMNATSHRPOLBCYP3A4 | |
| SCHEMBL28526429 | 0.69 | HTT (0.35) | HTT | |
| SCHEMBL9998883 | 0.69 | HTT (0.41) | HTTLMNATSHRPOLBCYP3A4 | |
| SCHEMBL28528413 | 0.65 | HTT (0.32) | HTT | |
| SCHEMBL28534032 | 0.65 | CYP2D6 (0.36) | HTTLMNATSHRPOLBCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2391597-B1 | METHOD FOR PRODUCING PURE CYCLODODECANONE | BASF SE (DE) | 2018-08-22 | — | — | EP | disclosed |
| US-8188320-B2 | Process for preparing pure cyclododecanone | BASF SE (DE) | 2012-05-29 | — | — | US | disclosed |
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | CCNA1, CYC1, CCNA2 | HTT 4816/4885LMNA 763/4885TSHR 4437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.